Liver Cirrhosis, Experimental
"Liver Cirrhosis, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.
| Descriptor ID |
D008106
|
| MeSH Number(s) |
C06.552.630.467 E05.598.500.468
|
| Concept/Terms |
Liver Cirrhosis, Experimental- Liver Cirrhosis, Experimental
- Cirrhosis, Experimental Liver
- Liver Cirrhoses, Experimental
- Experimental Liver Cirrhosis
- Hepatic Cirrhosis, Experimental
- Experimental Hepatic Cirrhosis
- Cirrhoses, Experimental Liver
- Experimental Liver Cirrhoses
|
Below are MeSH descriptors whose meaning is more general than "Liver Cirrhosis, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Liver Cirrhosis, Experimental".
This graph shows the total number of publications written about "Liver Cirrhosis, Experimental" by people in this website by year, and whether "Liver Cirrhosis, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Cirrhosis, Experimental" by people in Profiles.
-
A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease. J Hepatol. 2014 Jun; 60(6):1203-11.
-
Percutaneous intraportal application of adipose tissue-derived mesenchymal stem cells using a balloon occlusion catheter in a porcine model of liver fibrosis. J Vasc Interv Radiol. 2013 Dec; 24(12):1871-8.
-
Development of a large animal model of cirrhosis and portal hypertension using hepatic transarterial embolization: a study in swine. J Vasc Interv Radiol. 2011 Sep; 22(9):1329-34.
-
Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models. PLoS Genet. 2011 Jun; 7(6):e1002147.
-
Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis. J Hepatol. 2011 Aug; 55(2):445-52.
-
Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis. Lab Invest. 2009 Aug; 89(8):903-14.
-
Reduced susceptibility to epinephrine-induced arrhythmias in cirrhotic rats: the roles of nitric oxide and endogenous opioid peptides. J Hepatol. 2007 Mar; 46(3):432-9.
-
Primary cirrhotic hepatocytes resist TGFbeta-induced apoptosis through a ROS-dependent mechanism. J Hepatol. 2004 Jun; 40(6):942-51.
-
Epidermal growth factor is decreased in liver of rats with biliary cirrhosis but does not act as paracrine growth factor immediately after hepatectomy. J Hepatol. 2000 Aug; 33(2):275-81.
-
Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science. 2000 Feb 18; 287(5456):1253-8.